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Benzyloxycarbonyl(Z)-Leu-nLeu-H (calpeptin) and Z-Leu-Met-H, cell-penetrating mhtbitors of calpain. were found to block myoblast fusion 
without any effect on cell proliferation and alignment along then bipolar axts. They also inhibited the accumulation of creatine kinase during 
myogenesis. These effects were dose-dependent, and could be reversed upon removal of the drug from the culture medium. Furthermore, treatment 
of the inhibitors prevented the hydrolysis of filamm, which is sensitive to cleavage by calpam m vitro and interferes with actin-myosin filament 
formation by cross-linking F-actin molecules. On the other hand. leupeptm, which can also mhtbtt calpain m vitro but can not penetrate into cells, 
showed little or no effect on both myoblast fusion and filamin cleavage. These results suggest that calpam may play an important role m cytoskeletal 
reorganization that is requisite for myoblast fuston. The role of calpam on the expression of muscle-spectfic proteins remams unknown 
Calpain: Ftlamin. Calpeptin. Myoblast fusion 
1. INTRODUCTION 
A prominent event in myogenesis is the membrane 
fusion of mononucleated myoblasts to multinucleated 
myotubes [1,2]. This process absolutely requires influx 
of Ca’+ [3] and accompanies various cellular events, 
such as redistribution of membrane nroteins and reor- 
ganization of cytoskeletons [4,5]. A number of reports 
have suggested that protein breakdown plays an impor- 
tant role in mediating myoblast fusion [6-91. It has been 
shown that Ca’+-activated thiol-protease requiring mtl- 
limolar Ca” (m-calpain: henceforth referred to as cal- 
pain) is relocalized from cytosol to membrane during 
the fusion [7,8]. In addition, both the activity and pro- 
tein levels of calpain have recently been shown to in- 
crease dramatically during the early period of myogene- 
sis [9]. On the other hand, the activity level of calpas- 
tatin, an endogenous inhibitor of the protease [lo]. re- 
mains similar during the entire period of the cell culture. 
Therefore, calpain has been suggested to be a candidate 
protease involved in myoblast fusion. 
suggested that calpain may play an important role in 
cytoskeletal reorganization that is requisite for the cell 
fusion [9]. In an attempt to clarify the role of calpain, 
we examined the effect of cell-penetrating inhibitors of 
calpain on myoblast fusion and cleavage of filamin in 
cultured cells. 
2. MATERIALS AND METHODS 
Calpeptm and Z-Leu-Met-H were provided by Dr. Kambayashi 
[14]. The 80 kDa catalytic subunit of calpam, filamin. and creatine 
kmase were purified to apparent homogeneity as described previously 
[9]. Antibodies agamst the purtfied proteins were prepared by injecting 
each protein mto albino rabbits. Culture agents were obtamed from 
Gibco and “‘I-labeled protem A was from New England Nuclear. 
2.2. Cell culr1rrr 
Myoblasta from breast muscle of I?-day-old chick embryos were 
prepared as described previously [9.15]. The cells were plated on colla- 
gen-coated culture dishes at a concentration of 5 x lo5 cells/ml m 
Eagle’s essenttal medium containing 10% horse serum, 10% chick 
embryo extract and 1% antibtotlc/antimycotic solution. One day after 
cell seeding the culture medmm was changed with the same medium 
but contaming 2% embryo extract. When needed, calpain mhibttors 
were added to the culture medium at the time of medmm change. 
Filamin (250 kDa), which facilitates actin microfil- 
ament assembly and interferes with actin-myosin fila- 
ment formation [11,12], has been shown to be cleaved 
in cultured myoblasts to 240 kDa, in a manner similar 
to in vitro cleavage of the protein by calpain [9,13]. 
Furthermore, the hydrolysis of filamin is most evident 
at the period of myoblast fusion. Therefore, it has been 
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2.3 Initnunohlot anulysis 
Myoblasts cultured for appropriate periods were harvested m 20 
mM Trts-HCI buffer (pH 7) containmg 5 mM EDTA. The cells were 
disrupted by sonication for 30 s. and their extracts were obtamed by 
centrifugatton at 500 x g for 10 mm. Aliquots of the extracts were 
electrophoresed in 6 or 12% (w/v) polyacrylamtde gels m the presence 
of SDS as described [9]. After the electrophorews, proteins in the gels 
were transferred to nitrocellulose filters. and reacted wtth the antibody 
raised against the purified filamin or creatme kinase and then with 
“51-protein A. The filters were then drted and autoradiographed [16]. 
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3. RESULTS AND DISCUSSION 
To investigate the effect of calpeptin on myogenic 
differentiation, myoblasts that had been cultured for 24 
h were treated with the agent, and were observed under 
a microscope 48 h after the treatment. As shown in Fig. 
1, the cells treated with calpeptin failed to form myotu- 
bes, unlike the control cells. When the agent was re- 
moved from the culture, the cell fusion began within 24 
h. Of interest is the finding that the calpeptin-treated 
cells can still proliferate and align along their bipolar 
axis (Fig. IB). Also, addition of the agent to the cells, 
which were already committed to membrane fusion, 
showed little or no effect (data not shown). Therefore, 
calpeptin appears to specifically and reversibly block 
myotube formation but allow proliferation and align- 
ment of myoblasts. 
We also examined the effects of other inhibitors of 
calpain on myoblast fusion. As shown in Fig. 2, Z-Leu- 
Met-H, another cell-penetrating inhibitor of calpain 
[14], inhibited cell fusion in a dose-dependent manner. 
as did calpeptin, however, a significantly higher concen- 
tration of Z-Leu-Met-H was required to obtain a half- 
maximal inhibition of the fusion than calpeptin. On the 
other hand, leupeptin, a peptide aldehyde inhibitor of 
thiol-proteases, including calpain [ 171, showed little or 
no effect on the fusion, nor did E-64, an oxirane inhib- 
itor of thiol-proteases [IS], show any effect (data not 
shown). The latter two agents, unlike calpeptin, contain 
a positively charged guanidium group at neutral pH 
[19], and therefore it is likely that the differential effects 
of the calpain inhibitors on myoblast fusion are due to 
their ability to be transported across the cell membrane. 
Recently, we have shown that the activity and protein 
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Fig. 2. Dose-dependent effect of calpain mhtbitors on myoblast fusion. 
Myoblasts that had been cultured for 24 h were treated with increasmg 
amounts of calpeptin (o), Z-Leu-Met-H (A). and leupeptm (0). After 
the treatment. the cells were cultured for a further 48 h, stamed, and 
observed. Fuston mdex is defined as the percentage ofnuclet in myotu- 
bes compared to total nuclei. 
levels of calpain dramatically increase during the early 
period of myoblast fusion, and these increases almost 
coincide with the increased cleavage of the 250 kDa 
filamin to a 240 kDa product [9]. Because the fusion 
process is known to involve reorganization of cytoskel- 
etons in myoblasts [4.5], and because limited proteolysis 
of cytoskeletal components is generally accepted as one 
of the potential mechanisms for regulating cytoskeletal 
organization [20-221, we have suggested that calpain 
may play an important role in cell fusion [9]. To clarify 
this possibility further, myoblasts that had been cul- 
tured for 24 h were treated with cell-penetrating inhib- 
itors of calpain. After culturing the cells for a further 48 
C 
# 
Fig. 1. Inhibitton of myoblast fusion by calpeptin and its reversal. Myoblasts that had been cultured for 24 h were incubated for the next 48 h 
in the absence (A) and presence of 100 ,uM calpeptin (B). The cells Incubated with calpeptin for 24 h were freed of the drug and further cultured 
for 24 h. They were then observed under a phase contrast microscope (C). 
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Fig. 3. Effect of cell-penetrating inhibitors of calpain on the cleavage 
of filamin. Myoblasts that had been cultured for 24 h were treated with 
0 (lane a), 100 ,uM calpeptm (b) or 100 ,uM Z-Leu-Met-H (c). After 
the treatment, the cells were cultured for a further 48 h. harvested, and 
subjected to immunoblot analysis using anti-filamin antiserum as de- 
scribed in section 2 (A). The bands correspondmg to 250 kDa (~250) 
and 240 kDa (~240) were then cut out, and their radioactivity counted 
(B). 
h. they were harvested and subjected to immunoblot 
analysis using anti-filamin antiserum. Fig. 3 shows that 
the treatment of the inhibitors significantly reduced the 
conversion of the 250 kDa filamin to the 240 kDa prod- 
uct in the cells. Nearly identical data were obtained for 
cells treated with calpeptin for 24 h (data not shown). 
Of interest is the finding that calpeptin, which blocks the 
fusion more efficiently than Z-Leu-Met-H, reveals a 
more potent effect on the reduction of filamin cleavage 
than the latter agent. In contrast, leupeptin, which did 
not interfere with the fusion (see Fig. 2). showed little 
or no effect on the hydrolysis of filamin (data not 
shown). These results further support our suggestion 
that calpain plays an important role in cytoskeletal re- 
organization that is requisite for myoblast fusion. 
It is noteworthy. however. that the specificities of 
calpeptin and Z-Leu-Met-H are not just restricted to 
calpain. Both agents are also capable of inhibiting other 
thiol-proteases, such as cathepsin B [14,19]. Further- 
more, lysosomotrophic amines, such as chloroquine 
and ammonium chloride, have been reported to inter- 
fere with myoblast fusion [23], however, it appears less 
likely that lysosomal proteases are involved in cytoskel- 
eta1 reorganization, due to their subcellular location. In 
Fig. 4. Effect of cell-penetrating inhibitors of calpain on the accumu- 
lation of creatine kinase. Myoblasts that had been cultured for 24 h 
were treated with 0 (lane a), 100 PM calpeptin (b) or 100 ,uM Z-Leu- 
Met-H (c). After the treatment, the cells were cultured for a further 
48 h. The cells cultured for 24 h in the presence of 100 ,uM calpeptm 
were freed of the drug and further cultured for another 24 h (d). They 
were then harvested and subjected to immunoblot analysis using anti- 
creature kinase antiserum. 
addition, the calpain inhibitors do not contain any pri- 
mary amine group that protonates at acidic pH for 
accumulation inside lysosomes, unlike the lysosomotro- 
phic agents [24]. Furthermore, cathepsin B is unable to 
convert filamin into a 240 kDa product under the condi- 
tions tested for in vitro hydrolysis of the protein by 
calpain (data not shown). Nevertheless, a possibility 
that other unknown, cytosolic thiol-protease as well 
as lysosomal proteases, including cathepsin B, may be 
involved in myoblast fusion can not be entirely ex- 
cluded. 
During myogenic differentiation, myoblast fusion is 
known to occur concurrently with the induction of mus- 
cle-specific proteins, such as myosin, a-actin and 
creatine kinase, although these two processes can be 
uncoupled [25,26]. To examine whether calpeptin may 
also affect biochemical differentiation, the cells were 
cultured and subjected to immunoblot analysis as above 
but using the anti-creatine kinase antiserum. Fig. 4 
shows that accumulation of the protein is strongly ham- 
pered by calpeptin and less effectively by Z-Leu-Met-H. 
Calpain is known to hydrolyze in vitro protein kinase 
C, hormone receptors, epidermal growth factor and sev- 
eral calmodulin-binding proteins, and therefore is 
thought to modify signal transduction, the final step for 
regulation of gene expression in animal cells [27,28]. 
Thus, it appears possible that calpain may also play a 
role in regulation of the expression of muscle-specific 
proteins through limited proteolysis. although this pos- 
sibility is totally speculative at present. 
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